Italy Microvascular Complications of Diabetes Market 2022

1
PharmaPoint Microvascular Complications of
Diabetes Italy Drug Forecast and Market
Analysis to 2022byGlobalData

• Explore all reports for Diabetes Drugs market
• _at_
• http//www.rnrmarketresearch.com/reports/life-scie
  nces/pharmaceuticals/diseases-treatment/diabetes-d
  rugs .

2
PharmaPoint Microvascular Complications of
Diabetes Italy Drug Forecast and Market
Analysis to 2022

• The entire market for microvascular complications
  of diabetes (MCD) diabetic nephropathy,
  retinopathy, and neuropathy is facing an
  extremely high level of unmet need across the 7MM
  (US, 5EU and Japan). Despite its enormous
  potential, the MCD market is facing the major
  global barrier in the sparsely populated
  pipeline. The diabetic retinopathy segment of the
  market has recently seen rapid uptake of novel
  anti-VEGF therapies and is experiencing a strong
  growth. On the other hand, the diabetic
  neuropathy and nephropathy segments face the
  barrier in and increasing number of generic
  competitors.
• The uptake of drugs receiving additional approval
  for diabetic retinopathy/DME, such as Eylea,
  Iluvien and Ozurdex, will further drive sales in
  the MCD market. A dip in sales in the diabetic
  neuropathy market will happen from mid-2014 due
  to the patent expiry of Cymbalta. Another dip in
  sales in the diabetic neuropathy segment will
  happen around 2018, when Lyricas patent expires.
• Request sample copy of this report _at_
  http//www.rnrmarketresearch.com/contacts/request-
  sample?rname147959 .

3
PharmaPoint Microvascular Complications of
Diabetes Italy Drug Forecast and Market
Analysis to 2022

• Scope
• Overview of MCD including epidemiology, etiology,
  symptoms, diagnosis, pathology and treatment
  guidelines as well as an overview on the
  competitive landscape.
• Detailed information on the key drugs in Italy
  including product description, safety and
  efficacy profiles as well as a SWOT analysis.
• Sales forecast for the top drugs in Italy from
  2012-2022.
• Analysis of the impact of key events as well the
  drivers and restraints affecting the Italy MCD
  market.
• Complete report available _at_ http//www.rnrmarketre
  search.com/pharmapoint-microvascular-complications
  -of-diabetes-italy-drug-forecast-and-market-analys
  is-to-2022-market-report.html .

4
PharmaPoint Microvascular Complications of
Diabetes Italy Drug Forecast and Market
Analysis to 2022

• Reasons to buy
• Understand and capitalize by identifying products
  that are most likely to ensure a robust return
• Stay ahead of the competition by understanding
  the changing competitive landscape for MCD
• Effectively plan your MA and partnership
  strategies by identifying drugs with the most
  promising sales potential
• Make more informed business decisions from
  insightful and in-depth analysis of drug
  performance
• Obtain sales forecast for drugs from 2012-2022 in
  Italy
• Request sample copy of this report _at_
  http//www.rnrmarketresearch.com/contacts/request-
  sample?rname147959 .

5
PharmaPoint Microvascular Complications of
Diabetes Italy Drug Forecast and Market
Analysis to 2022

• Table of Contents
• 1 Table of Contents 61.1 List of Tables 91.2
  List of Figures 11
• 2 Introduction 122.1 Catalyst 122.2 Related
  Reports 13
• 3 Disease Overview 153.1 Etiology and
  Pathophysiology 173.1.1 Diabetic Nephropathy
  173.1.2 Diabetic Retinopathy 193.1.3 Diabetic
  Neuropathy 203.2 Prognosis 213.3 Quality of
  Life 223.4 Symptoms 23
• Request sample copy of this report _at_
  http//www.rnrmarketresearch.com/contacts/request-
  sample?rname147959 .

6
PharmaPoint Microvascular Complications of
Diabetes Italy Drug Forecast and Market
Analysis to 2022

• For more details contact Mr. Priyank Tiwari
  sales_at_rnrmarketresearch.com / 18883915441

RnR Market Research RnRMarketResearch.com, an
online repository of market  research reports,
offers in-depth analysis of over 5000 market
segments. RnR  Market Research library has
syndicated reports by leading market research 
publishers across the globe.